Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy ...

The trial randomized 751 participants across the U.S. and Puerto Rico in a 1:1 ratio to receive maximum tolerated dose of Zepbound (10 mg or 15 mg) or Wegovy (1.7 mg or 2.4 mg). With tirzepatide ...

Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy In key secondary endpoints, Zepbound was superior to Wegovy across all weight reduction targets and waist ...

In an emailed comment, Novo Nordisk said the Eli Lilly trial evaluated the maximum dose of Zepbound 10 mg or 15 mg to 1.7 mg or 2.4 mg in semaglutide. "The highest dose of tirzepatide is five ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.